Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial.
Xiaowu ZhangYingen LuoJiaywei TsauoHe ZhaoTao GongJingui LiYawei LiHuiying ZengWei SunXiao LiPublished in: European radiology (2022)
• Transradial access (TRA) enabled early ambulation after transarterial chemoembolization (TACE), resulting in significant increase in activities of daily living and health-related quality of life (HRQoL) compared to transfemoral access (TFA) when vascular closure devices were not used. • Procedural variables (contrast agent dose, fluoroscopy time, procedure time, air kerma, dose-area product, length of hospital stay, and total cost) were not significantly different between patients who received TRA-TACE and TFA-TACE. • The incidence and severity of adverse events were similar between patients who received TRA-TACE and TFA-TACE.
Keyphrases
- radiofrequency ablation
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- percutaneous coronary intervention
- aortic valve replacement
- healthcare
- magnetic resonance
- liver metastases
- risk factors
- emergency department
- minimally invasive
- magnetic resonance imaging
- heart failure
- aortic valve
- left ventricular
- drug induced
- catheter ablation